Clinical Trial Update: MPR for Stroke Risk Assessment of ICAS

View source ↗

Summary

A recruiting clinical trial at Xuanwu Hospital, Beijing, evaluating MPR for stroke risk assessment in intracranial atherosclerosis (ICAS) and ischemic stroke, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Atherosclerosis
• Stroke

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: ICAS - Intracranial Atherosclerosis, Stroke Ischemic | Status: RECRUITING